Naukowcy Celon Pharma na kongresie ECNP.
Kongres ECNP to najważniejsze w Europie spotkanie naukowe w obszarze neuropsychiatrii, skierowane do psychiatrów, neurologów i psychologów z całego świata. W tym roku 10 października Dr Joanna Krzemien oraz Dr Mikolaj Matloka będą mieli przyjemność zaprezentowania w Barcelonie posteru podsumowującego wyniki I fazy dla inhibitora PDE10a. Zachęcamy do zapoznania się z wydarzeniem – ECNP 2023Read more »
Welcome to Celon Pharma S.A.
Celon Pharma S.A. is an integrated pharmaceutical company which conducts advanced research and manufactures modern drugs. The company is also a successful marketing authorisation holder for it products. The drugs we offer help thousands of patients lead a better and longer life.
News
- Current report No. 17/2023 K – Resolutions adopted by the Ordinary General Meeting of Celon Pharma S.A. on June 22, 2023 – correctionDate prepared: June 27, 2023 Abbreviated name of the issuer: CELON PHARMA S.A. Subject: Resolutions adopted by the Ordinary General Meeting of Celon Pharma S.A. on June 22, 2023 – … Read more
- Current report No. 18/2023 – List of shareholders holding at least 5% of the votes at the Ordinary General Meeting of Celon Pharma S.A. held on June 22, 2023Date prepared: June 22, 2023 Abbreviated name of the issuer: CELON PHARMA S.A. Subject: List of shareholders holding at least 5% of the votes at the Ordinary General Meeting of … Read more
- Current report No. 17/2023 – Resolutions adopted by the Ordinary General Meeting of Celon Pharma S.A. on June 22, 2023Date prepared: July 22, 2023 Abbreviated name of the issuer: CELON PHARMA S.A. Subject: Resolutions adopted by the Ordinary General Meeting of Celon Pharma S.A. on June 22, 2023. Legal … Read more
